We have been developing both local and systemic gene stained cells and decreased slightly the specific T cell subtherapy approaches to treat inflammatory and autoimmune sets. The ability of these proteins to protect the transdiseases. To determine if systemic, constitutive expression planted mice from endotoxin treatment was determined by of biologically active anti-inflammatory agents is therameasuring serum interleukin-6 (IL-6) and interleukin-10 (ILpeutic and/or has associated toxicity, mouse hematopoietic 10) responses after LPS injection at 1.5, 3, 4.5 and 24 h stem cells were infected with retroviral vectors carrying the after treatment. The IL-1Ra group showed diminished ILgenes for human IL-1 receptor antagonist (IL-1Ra), human 10 levels and less mortality after injection of LPS compared soluble TNF receptor p75 (sTNFR), or the ␤-galactosidase to the lacZ controls. Mice expressing sTNFR had lower IL-(lacZ) gene, and transplanted into lethally irradiated recipi-10 and IL-6 levels following injection of LPS. These results ents. The serum levels of human IL-1Ra and human demonstrate that constitutive, systemic expression of ILsTNFR in the long-term reconstituted mice, 2-7 months 1Ra and sTNFR is able to confer partial protective effects after transplantation, were 596 and 158 ng/ml respectively.
Introduction
and correlate with IL-6 levels early in the disease. [12] [13] [14] Interleukin-1 beta (IL-1␤) and tumor necrosis factor alpha Thus, both IL-6 and IL-10 are downstream mediators as (TNF␣) are important mediators of inflammation and are well as markers of the inflammatory cytokine cascade. induced by many agents including endotoxin. Endotoxin-IL-1 receptor antagonist protein (IL-1Ra) and soluble induced IL-1␤ and TNF␣ stimulate the expression of a TNF receptors (sTNFR) p55 and p75 are endogenous subvariety of other cytokines such as interleukin-6 (IL-6) and stances induced by inflammatory stimuli such as endointerleukin-10 (IL-10). IL-6 is produced by mononuclear toxin which are capable of specifically inhibiting the phagocytes, endothelial cells, and T cells in response to activity of IL-1␤ and TNF␣ respectively. [15] [16] [17] [18] [19] [20] [21] Although IL-LPS, TNF␣ and IL-1␤. IL-6 stimulates growth and differ1Ra is structurally similar to IL-1␤, and binds to the ILentiation of T and B cells and stimulates the production 1 receptor (type I) with a similar affinity, it exhibits no of acute phase proteins. 1 Because circulating levels of ILagonist activity. 18 The soluble TNF receptors are trunc-6 are consistently increased and correlate with severity ated derivatives of the parent molecules comprising the of illness in human septic shock, it is considered to be a extracellular regions of the two types of TNF receptor, marker of systemic inflammation. [2] [3] [4] [5] p55 and p75, that are capable of decreasing TNF␣ activity IL-10 is produced by T cells and activated macroin vitro and in vivo. 17 Administration of large doses of ILphages in response to LPS, TNF␣, and IL-1␤ and has anti1Ra (1-750 g) 15, 19, 20 the MFG retroviral vector to transfer the gene for human IL-1Ra both locally to joint tissues for treatment of arthritis [29] [30] [31] and systemically via delivery to murine hematopoietic stem cells. 32 In the latter model, hematopoietic stem cells were first transduced in culture and then transplanted into lethally irradiated recipients, resulting in long-term bone marrow reconstitution and systemic constitutive expression of IL-1Ra. 32 The level of serum IL1Ra in the long-term reconstituted mice ranged from 100-800 ng/ml of IL-1Ra and expression was stable for more than 1 year. 32 The exogenous hIL-1Ra found in the serum was shown to be biologically active in vitro. Transplantation of genetically modified hematopoietic stem cells thus can be used to readily establish mice constitutively expressing immunomodulatory proteins. 32 These mice can then be used to determine whether specific immunomodulatory proteins, delivered by gene transfer, have protective effects in animal models of inflammatory diseases. the peripheral blood mononuclear cell profile, however, sTNFR (p75) expression increased B cells and monocytes and decreased specific T cell subsets. Groups of mice of intraperitoneal injection of 25 g of LPS and of serial phlebotomy on IL-10 and IL-6 levels was examined in expressing IL-1Ra or sTNFR were injected with endotoxin to determine whether constitutive expression of normal, nontransplanted C57BL6/J mice at 0, 1.5, 3, 4.5 and 24 h after injection. Serum IL-10 and IL-6 levels are these proteins could protect against the vigorous acute systemic inflammatory response induced by endotoxin. depicted in Figure 2a and b. These data demonstrate a significant IL-10 and IL-6 response to LPS which peaked The constitutive, systemic expression of IL-1Ra or sTNFR (p75) attenuated the acute effects of endotoxin as measat 3-4.5 h and resolved by 24 h. Saline injected controls demonstrated baseline levels throughout and also demured by the pro-inflammatory marker, IL-6 and the antiinflammatory marker, IL-10. These data demonstrate that onstrated that our technique of injection, intravenous saline bolus, and phlebotomy did not induce a significant gene transfer methods, resulting in long-term systemic expression of cytokine antagonist proteins, may be useful IL-10 or IL-6 response.
To examine the ability of systemically expressed in the therapy of inflammatory diseases in which IL-1␤ and TNF␣ are important mediators.
human IL-1Ra or human sTNFR to attenuate the IL-10 and IL-6 response induced by LPS, mice expressing IL1Ra , sTNFR (p75), or lacZ (as controls), were injected Results with 25 g LPS ( Figure 3 ). Because of the mortality observed at the 25 g dose, the experiment was repeated Generation of mice constitutively expressing IL-1Ra or with a 5 g dose of LPS in a second group of each type sTNFR (p75) by transplantation of genetically modified of mice ( Figure 4 ). The IL-10 response to 25 g of LPS hematopoietic stem cells was significantly attenuated in the IL-1Ra expressing Mice expressing IL-1Ra, sTNFR (p75), or lacZ were genermice compared to lacZ expressing mice by two-way ated by transplantation of hematopoietic stem cells, genrepeated measures ANOVA (P Ͻ 0.05, Figure 3a ). Both etically modified by retroviral infection, into lethally groups returned to baseline by 24 h. The IL-6 response in irradiated recipients. Following long-term reconstitution the IL-1Ra mice was initially the same as lacZ, however, it (2-7 months), the serum levels of human IL-1Ra and began to resolve earlier with a 20% reduction at 4.5 h. sTNFR (p75) were determined ( Figure 1 ). Two groups of
The difference, however, between groups did not reach IL-1Ra expressing mice were used for this project and significance (P = 0.16, Figure 3b ). When injected with 5 their baseline serum IL-1Ra level were 838 and 101 g of LPS, the IL-10 and IL-6 response was similar in the ng/ml. Two groups of sTNFR expressing mice were used IL-1Ra mice compared with the lacZ mice ( Figure 4a and and their serum sTNFR (p75) levels were 134 and 207 b). The IL-10 and IL-6 response to 25 g of LPS in the ng/ml. As previously noted, elevated serum levels of ILsTNFR (p75) mice was significantly attenuated compared 1Ra and sTNFR(p75) remained relatively constant for up with lacZ (P Ͻ 0.05, Figure 3a and b). The IL-10 and ILto 1 year (data not shown). It is important to note that this group of irradiated mice, which were reconstituted with retrovirally transTo determine if the systemic levels of human IL-1Ra or human sTNFR (p75) achieved were sufficient to block an duced bone marrow stem cells, produced more IL-6 and had more mortality from 25 g of LPS (P = 0.05) than acute inflammatory response, the mice were challenged with the potent inflammatory challenge, LPS. The effect nontransplanted C57BL6/J mice. Mortality 24 h after 25 g LPS was seven of 11 in the lacZ group, two of 11 blood mononuclear cells proportions varied slightly between mice groups. The pooled, total white blood cell in the IL-1Ra group, five of 11 in the sTNFR group, and none of 12 in the normal mice. Even with this small numcounts were the same in normal, nontransplanted mice (13 042/mm 3 ), lacZ expressing mice (13 982/mm 3 ), and ber of mice, the difference in mortality between the IL1Ra and lacZ mice approached statistical significance (P IL-1Ra expressing mice (14 344/mm 3 ). A 30% decrease, however, was seen in the sTNFR (p75) group = 0.08). No difference was seen between the sTNFR and lacZ expressing mice (P = 0.4).
(9904/mm 3 ). Furthermore, in the sTNFR (p75) mice a 27 and 24% increase in B cells and monocytes (B220 and MAC.1 positive cells) respectively and a 49, 39, 41 and Effect of constitutive IL-1Ra or sTNFR on the PBMC profile 47% decrease in the T cell subsets CD4, CD8, ␣␤ TCR, and ␥␦ TCR positive cells respectively was seen. These To determine whether the systemic constitutive expression of IL-1Ra and/or sTNFR affected hematopodata suggest that while IL-1Ra has little effect on the total white blood cell count and PBMC subgroups, inhibition iesis, the peripheral blood mononuclear cell (PBMC) profile was determined. As shown in Figure 5 , peripheral of TNF␣ has more pronouced effects on hematopoiesis. cytokine antagonists such as IL-1Ra and sTNFR have a
Figure 4 (a) Serum IL-10 levels (mean ± s.e.m.) induced by injection of 5 g LPS intraperitoneally were lower in mice expressing sTNFR (p75) (̆) than in control mice expressing lacZ (b); (P Ͻ 0.05 two-way repeated measures ANOVA), (*P Ͻ 0.05 at each time-point). IL-1 Ra () expressing mice did not have significantly lower levels than lacZ expressing mice (n = 5-6 per group). (b) Serum IL-6 levels (mean ± s.e.m.) induced by injection of 5 g LPS intraperitoneally were lower in mice expressing sTNFR (p75) (̆) than in control mice expressing lacZ (b); (P Ͻ 0.05 two-way repeated measures ANOVA); (*P Ͻ 0.05 at each time-point). IL-1 Ra () expressing mice did not have significantly lower levels than lacZ expressing mice (n = 5-6 per group).

Figure 5 Peripheral blood mononuclear cell profile in mice expressing
Discussion
protective effect when administered concurrently or shortly after LPS injection. LPS induces both TNF␣ and Gene therapy has been applied to the treatment of many IL-1␤ which in turn, induce IL-6 and IL-10 as well as different types of genetic and acquired diseases. Howother cytokines. 17, 20, 25, 26 Serum levels of IL-6 and IL-10 ever, until recently, gene transfer methods have not been were chosen as common indicators of activation of the applied to treating inflammatory diseases. We have demcytokine cascade downstream from the proposed site of onstrated that local gene transfer of the IL-1Ra gene to action of both IL-1Ra and sTNFR (p75). 13, 20, 25, 26 Our synovial cells in the rabbit knee joint is therapeutic in a results demonstrate the ability of constitutive, systemic rabbit model of arthritis; however, for treatment of sysexpression of sTNFR (p75) to blunt the IL-6 and IL-10 temic or multifocal inflammatory diseases, we have sugresponse to LPS. A significant effect on IL-10 levels, but gested systemic, rather than local, gene delivery. [27] [28] [29] [30] [31] In only a marginal effect on IL-6, was seen from the this article, we examined the ability of constitutively expression of IL-1Ra. The level of suppression of the marexpressed, systemic IL-1Ra and sTNFR (p75) in the kers chosen here, IL-6 and IL-10, however, was not as ng/ml range to protect mice from the effects of endodramatic as the effects observed in mice injected with toxin, an acute, potent inflammatory challenge to demonhigh doses of recombinant IL-1Ra or sTNFR protein in strate the plausibility of systemic therapy.
Many studies have demonstrated that high doses of other reports. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Constitutive expression in the ng/ml range achieved here may not equal bolus injection of retroviral producer cell lines, infection of harvested bone marrow stem cells, and transplantation of these stem cells microgram doses of IL-1Ra or sTNFR protein. Serum levels after bolus injection were not documented in into irradiated recipient C57BL6/J mice were performed as previously described. 29, 32, 33 MFG-lacZ retroviral vector other reports, so direct comparison of these approaches is difficult.
was used as a control. The IL-1Ra and sTNFR expressing mice demonstrated a different pattern of suppression of IL-10 and IL-6.
LPS challenge Expression of IL-1Ra suppressed the IL-10 response more A dose of 25 g of LPS-B from Salmonella typhosa was effectively than the IL-6 response. The relative sensipreviously established as sublethal in this mouse strain. 34 tivities of IL-10 and IL-6 induction by IL-1␤ are unknown; Normal mice, lacZ, IL-1Ra, and sTNFR expressing mice however, our data suggest that the IL-10 response is more (11 per group) were injected with 25 g of LPS in 0.1 ml sensitive than the IL-6 response to agents which block ILnormal saline intraperitoneally. A group of nontrans-1␤. Overall, the effect of IL-1Ra was less dramatic than planted mice received 0.1 ml normal saline intraperitonethat of sTNFR (p75) at the levels of IL-1Ra or sTNFR (p75) ally. The mice were phlebotomized by retro-orbital puncexpression achieved in these mice. It is possible that ILture with a glass capillary tube obtaining approximately 6 is induced primarily as a result of TNF␣ induction 70 l of blood at 0, 1.5, 3, 4.5 and 24 h after LPS injection. which is unaffected by IL-1Ra. 21 The second group of ILAfter the 1.5 h bleed the mice all received a 0.5 ml normal 1Ra mice expressed significantly lower baseline levels of saline bolus by tail vein injection to counter the possible human IL-1Ra compared to the first group (101 versus 838 effects of intravascular volume depletion from phlebong/ml, P Ͻ 0.05). This may explain the lack of suptomy. Whole blood was centrifuged and the decanted pression of IL-10 levels in the second batch of IL-1Ra serum was frozen at −80°C. Serum IL-6 and IL-10 levels mice despite being injected with a smaller dose of LPS.
were determined at each time-point. The groups of mice The variability in protein expression between batches of were matched with regard to age, and to time after bone mice is thought to be due to differences in the efficiency marrow transplantation. It was 2-7 months after transof retroviral infection and no doubt contributes to the plantation for all the mice at the time of LPS adminisvariability in the IL-10 and IL-6 responses, making stattration. A second group of mice (five to six from each istical significance more difficult to reach.
group, IL-1Ra, sTNFR (p75), and lacZ) were injected with More effective suppression of both cytokines was a lower dose, 5 g LPS and treated in the same fashion observed in the sTNFR (p75) mice compared with the ILas the first group. 1Ra mice. Like IL-1Ra, however, the presence of sTNFR (p75) blunted the IL-10 response more effectively than the ELISA assays IL-6 response. Unlike IL-1Ra, sTNFR (p75) blunted the Baseline IL-1Ra and sTNFR (p75) serum levels were IL-6 response throughout the time course after either determined by ELISA. The IL-1Ra and sTNFR p75 ELISA dose of LPS. Mohler et al 17 reported that sTNFR in the kits (R&D Systems, Minneapolis, MN, USA) were used monomeric form had partial agonist activity causing an according to the manufacturer's instructions. Detection increase in the serum TNF␣ level late after LPS adminislimits were 22 pg/ml and 5 pg/ml respectively. Mouse tration. These data showed resolution of the LPS effect IL-6 and IL-10 levels were also measured by ELISA with a similar time course as the IL-1Ra and lacZ group (Pharmingen, San Diego, CA, USA) with a detection limit which does not support a continued TNF␣ effect late after of 20 pg/ml. LPS administration. A more pronounced effect from sTNFR (p75) compared with IL-1Ra implies that TNF␣ contributed more significantly than IL-1␤ to IL-6 and IL-FACS analysis of peripheral blood mononuclear cells 10 induction and suggests that any TNF␣-dependent IL-(PBMC) 1␤ induction may be blocked as well. Ideally, inhibition Heparinized whole blood obtained by exsanguination via of both IL-1␤ and TNF␣ simultaneously would result in the inferior vena cava from two mice of each group a more dramatic reduction in IL-6 levels.
(nontransplanted mice, lacZ, IL-1Ra, and sTNFR expressTaken together, our results suggest that systemic ing mice, 3-4 months after transplantation) was layered expression of these immunosuppressive proteins is paron to lymphocyte separation medium and centrifuged at tially protective against acute challenge and that their 400 g at RT for 30 min. The buffy coat was harvested, constitutive expression is not detrimental to the mice.
washed, and separated into four samples. Two-color Thus, gene therapy could be applied to treatment of labeling of the PBMC was performed with phycoerythrin chronic inflammatory conditions. Further work, however, (PE)-labeled MAC.1 and fluorescein isothiocyanate-labwill be necessary to examine the utility of constitutive or eled (FITC) B220 antibodies, PE-labeled ␣␤ TCR and regulated expression of cytokine antagonists in chronic FITC-labeled ␥␦ TCR, PE-labeled CD8 and FITC-labeled inflammatory conditions. Although we used the hemato-CD4, and PE and FITC-labeled Leu4, a human T cell antipoietic stem cell as the target for retroviral gene delivery gen-specific irrelevant control antibody. All antibodies in these studies, the clinical application of systemic gene were obtained from Pharmingen. Fluorescence activated therapy for inflammatory diseases would have to utilize cell sorter analysis was performed on the para-formalother cell types such as T cells or fibroblasts for systemic dehyde-fixed cells. gene delivery.
Statistical analysis
Materials and methods
Two-way repeated measures ANOVA was used to compare cytokine levels between groups at different time-
Retroviral vector
The MFG-IL-1Ra, MFG-sTNFR (p75) and MFG-lacZ vecpoints. Fisher's exact test was used to compare mortality between groups. tors have been previously described. 29, 32, 33 Generation of
